From genetic abnormality to metastases: murine models of breast cancer and their use in the development of anticancer therapies

Author： Ottewell P.D. Coleman R.E. Holen I.

Publisher： Springer Publishing Company

ISSN： 0167-6806

Source： Breast Cancer Research and Treatment, Vol.96, Iss.2, 2006-03, pp. : 101-113

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Attributes of brain metastases from breast and lung cancer

By Hengel Kyle

International Journal of Clinical Oncology, Vol. 18, Iss. 3, 2013-06 ,pp. : 396-401

Springer Publishing Company

Access to resources Recommend Favorite

Development of an EORTC disease-specific quality of life questionnaire for use in patients with liver metastases from colorectal cancer

By Kavadas V. Blazeby J.M. Conroy T. Sezer O. Holzner B. Koller M. Buckels J. on behalf of the EORTC Quality of Life Group

European Journal of Cancer, Vol. 39, Iss. 9, 2003-06 ,pp. : 1259-1263

Elsevier

Access to resources Recommend Favorite

The use of complementary therapies by breast cancer patients attending conventional treatment

By Crocetti E. Crotti N. Feltrin A. Ponton P. Geddes M. Buiatti E.

European Journal of Cancer, Vol. 34, Iss. 3, 1998-02 ,pp. : 324-328

Elsevier

Access to resources Recommend Favorite

Acquisition of metastatic tissue from patients with bone metastases from breast cancer

By Hilton J.

Breast Cancer Research and Treatment, Vol. 129, Iss. 3, 2011-10 ,pp. : 761-765

Springer Publishing Company

Access to resources Recommend Favorite

Anticancer effects of metformin and its potential use as a therapeutic agent for breast cancer

By Guppy Amy Jamal-Hanjani Mariam Pickering Lisa

Future Oncology, Vol. 7, Iss. 6, 2011-06 ,pp. : 727-736

Future Medicine

Access to resources Recommend Favorite